Evidence map›Paper›PMID 16905579›Full record

ArticleAnnals of the rheumatic diseases2006

Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time.

G S Alarcón, J Calvo-Alén, G McGwin, A G Uribe, S M A Toloza, J M Roseman, M Fernández, B J Fessler, L M Vilá, C Ahn and 3 more

Erratum issuedOpen access · greenAbstract readMulticenter Study
In one paragraph

Article in Annals of the rheumatic diseases, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 64 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 1 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 1 synthesis or guideline pooled it, 128 citations in OpenAlex.

  1. Guideline
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

G S AlarcónDepartment of Medicine, Division of Clinical Immunology and Rheumatology, School of Medicine, The University of Alabama at Birmingham, Birmingham, AL 35294, USA. graciela.alarcon@ccc.uab.edu
J Calvo-Alén
G McGwin
A G Uribe
S M A Toloza
J M Roseman
M Fernández
B J Fessler
L M Vilá
C Ahn
F K Tan
J D Reveille
LUMINA Study Group
University of Alabama at Birmingham · US

Funding

Zevalin Radioimmunotherapy Using a Modified TreatmentM01RR000032 · NCRR · UNIVERSITY OF SOUTHERN CALIFORNIA · PI RICH, ROBERT R. · 1985 to 2008
$23.6M
VALIDATION OF THE CLINICAL DEMENTIA RATING SCALEP20RR011126 · NCRR · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI KRAISELBURD, EDMUNDO NELSON · 1995 to 2009
$11.2M
Zolmitriptan challenge and human performance testingM01RR002558 · NCRR · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI SCHULTZ, STANLEY G · 1985 to 2006
$10.3M
OUTCOME OF SYSTEMIC LUPUS ERYTHEMATOSUS IN MINORITIESR01AR042503 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ALARCON, GRACIELA S · 1993 to 2004
$2.1M
NCRR NIH HHS 1P20RR11126NCRR NIH HHS M01 RR000032NCRR NIH HHS M01-RR00032NCRR NIH HHS M01 RR002558NCRR NIH HHS M01-RR02558NCRR NIH HHS P20 RR011126NIAMS NIH HHS R01 AR042503NIAMS NIH HHS R01-AR42503
6 · The paper itself

Abstract

aimTo ascertain the predictive factors of high levels of disease activity in systemic lupus erythematosus (SLE). PATIENTS AND

methodsPatients with SLE (American College of Radiology criteria), aged >or=16 years, with disease duration <or=5 years and of Hispanic (Texas and Puerto Rico), African American and Caucasian ethnicities, were included. The outcome was high disease activity at any time (Systemic Lupus Activity Measure-Revised >10). A basic multivariable model (including age, sex, ethnicity, health insurance, social support, abnormal illness-related behaviours, helplessness and prior disease activity) was first examined. Additional models were built by including other variables.

results554 patients (100 Hispanics from Texas, 94 Hispanics from Puerto Rico, 199 African Americans, 161 Caucasians) and 2366 visits were analysed; 47% of the patients and 29% of the visits met the definition of high disease activity (more common among African Americans (72.0%) and Hispanics from Texas (71.3%) than among Caucasians (43.9%) and Hispanics from Puerto Rico (31.9%)). Variables found to predict high levels of disease activity were Hispanic (from Texas) and African American ethnicities, lack of health insurance, helplessness, abnormal illness-related behaviours and poor social support; age was negatively associated with high levels of disease activity. African admixture and anti-double-stranded DNA antibodies also predicted high levels of disease activity, as did prior disease activity. None of the human leucocyte antigen variables were retained in the models.

conclusionsSocioeconomic-demographic (age, ethnicity, health insurance), behavioural and psychological variables are important mediators of high levels of disease activity in SLE during its course. Interventions aimed at modifiable factors may improve the outcomes of SLE.

Indexed as

AdolescentAdultAge FactorsBlack or African AmericanEpidemiologic MethodsFemaleHispanic or LatinoHumansLupus Erythematosus, SystemicMalePrognosisSeverity of Illness IndexSick RoleSocial SupportSocioeconomic FactorsWhite People

Identifiers

PMID16905579
PMCPMC1798273
OpenAlexW2136391054

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.